Australian Associated Press on MSN
Smiggle sets its sights and range on primary target
Smiggle will cut product ranges aimed at children younger than six and re-establish its identity as the back-to-school brand of choice for kids aged six to 12.
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results